Tumour Registry Breast Cancer

NCT01351584 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4500

Last updated 2025-08-28

No results posted yet for this study

Summary

The registry aims to collect and analyse information on the antineoplastic treatment of breast cancer in daily routine practice of office-based and clinic-based medical oncologists in Germany.

Conditions

Sponsors & Collaborators

  • Arbeitskreis Klinische Studien

    collaborator OTHER
  • Arbeitsgemeinschaft fur Internistische Onkologie

    collaborator OTHER
  • iOMEDICO AG

    lead INDUSTRY

Principal Investigators

  • Hans Tesch, MD

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-02-28
Primary Completion
2021-12-31
Completion
2021-12-31

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01351584 on ClinicalTrials.gov